Ege University, Turkey
Malignant cerebral tumor diagnosis enhanced by perfusion and diffusion MRI
Published in Telemedicine Business Week, August 23rd, 2006
"Common contrast-enhancing malignant tumors of the brain are glioblastoma multiforme (GBMs), anaplastic astrocytomas (AAs), metastases, and lymphomas, all of which have sometimes similar conventional MRI findings. Our aim was to evaluate the role of perfusion MR imaging (PWI) and diffusion-weighted imaging (DWI) in the differentiation of these contrast-enhancing malignant cerebral tumors. Forty-eight patients with contrast-enhancing and histologically proven brain tumors, 14 AAs, 17 GBMs, 9 metastases, and 8 lymphomas, were included in the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Business Week
More Articles from Telemedicine Business Week
- Amphion Innovations
Amphion Innovations' partner company raises $3.5 million in series C financing - Connect Imaging
Connect Imaging signs joint development agreement with Ashva Technologies - Hologic
Hologic announces $75 million senior unsecured credit facility - Hologic
Hologic announces Q3 revenues of $119,685,000, a 62% increase from last year - TriPath Imaging
TriPath Imaging reports Q2 2006 earnings per share of 4 cents, 9 cents for first half 2006 - Aarhus University Hospital, Aarhus, Denmark
Left ventricular ejection fraction assessment may invalidate the reliability of EuroSCORE - More from this issue of Telemedicine Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
